The cover of JBI Evidence Synthesis floating on a blue triangle background

Impact Factor 6.8

JBI Evidence Synthesis’ latest impact factor

We are delighted to announce that JBI Evidence Synthesis has received a Journal Impact Factor of 6.8.

JBI Evidence Synthesis has also achieved:

  • Q1 in Health Care Sciences & Services (JCR) 
  • Q1 in General Nursing (Scopus)
  • Q1 in General Medicine (Scopus)

Associate Professor Aromataris, Editor-in-Chief, recognised the collective efforts of the many individuals behind this accomplishment. He extended his sincere thanks to both past and present members of the editorial office, the advisory board, the editorial panel, authors, and the hundreds of volunteer peer reviewers whose dedication has been essential in upholding the journal’s high standards.

Image of A/Prof Eduardo Aromataris along with the quote: 'We are thrilled that the JB Evidence Synthesis impact factor has risen to 6.8. This is a significant milestone for our journal. Thank you to our editorial office, advisory board, editors and peer reviewers - and most importantly, thank you to our authors who have helped us to establish a high-quality periodical."

JBI Evidence Synthesis is focused on disseminating rigorous, high-quality research that provides the best available evidence to inform healthcare policy and practice. It is the premier channel for diverse evidence syntheses that move beyond systematic reviews of effectiveness. The journal publishes evidence synthesis methodology papers, diverse types of systematic reviews, and scoping reviews covering multidisciplinary healthcare topics. 

All publications follow JBI’s gold-standard, rigorous methodology and methods developed by JBI’s international scientific committee, and external methodologies that are endorsed by JBI: systematic reviews of prevalence and incidence; diagnostic test accuracy; and measurement properties.